EVALUATION OF SALIVA AS LIQUID BIOPSY FOR EARLY DETECTION OF ORAL CANCER IN PATIENTS WITH ORAL-SUBMUCOUS FIBROSIS (OSMF)
Saliva as Early Detection Tool for Oral Cancer
Liaquat University of Medical & Health Sciences
1,000 participants
Jun 1, 2021
OBSERVATIONAL
Conditions
Summary
Oral cancer is the top cancer in Pakistan, accounting for 27%, and it has a high mortality rate due to late-stage diagnosis. It primarily affects the lips, tongue, cheeks, and floor of the mouth. Major risk factor for oral cancer development is pan supari chhaliya chewing. Patients often develop a pre-malignant condition, oral submucous fibrosis, resulting in limited mouth opening. Thus, patients are diagnosed at an advanced level and poor survival. Therefore, saliva appears a potential mode of evaluation for early detection. This project aims to evaluate salivary cells, genes and biochemistry of the saliva among health volunteers and compare it with that of the patients with oral submucous fibrosis and oral cancer.
Eligibility
Inclusion Criteria3
- healthy volunteers
- patients with oral submucous fibrosis
- patients with biopsy proven oral cancer
Exclusion Criteria1
- patients with oral infection
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Three groups will be compared on the basis of cytology, genes and biochemical analysis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07122128